Objective: To examine the variability of serum estrogens in response to transdermal estrogen replacement therapy (ET), and to determine the effects on androgens and sex hormone binding globulin (SHBG).
Design: Randomized, double-blind, placebo-controlled study.
Setting: Women's hospital.